Diasorin CE Marks New Simplexa Flu A/B & RSV Direct Gen II Assay to Run with Simplexa COVID-19 Direct Assay
DiaSorin Molecular LLC (Cypress, CA, USA) has CE marked its Simplexa Flu A/B & RSV Direct Gen II kit to run alongside its Simplexa COVID-19 Direct kit.
Latest News
- BD Launches Portable, Rapid POC Antigen Test to Detect SARS-CoV-2 in 15 Minutes
- Pneumonia Panel Evaluated for Lower Respiratory Tract Infection
- Gut Microbiome Metabolomic Profiles Are Diagnostic for Liver Diseases
- DNA Sequencing Technique Unravels Genetic Diversity of Cancer Tumors
- An Eight MicroRNA Biomarker Panel for Diagnosis of ALS
- Geochemistry Test Identifies Osteoporosis Earlier Than Standard Method
- RNA Sequencing as Alternative to Immunohistochemistry in Cancer Diagnostics
- Immune Cells Hampered Fighting Soft Tissue and Bone Sarcomas
Product Showcase
COVID-19 IGG/IGM DETECTION KIT
The COVID-19 IgG/IgM Detection Kit (Colloidal Gold) requires one sample drop of blood, serum or plasma to deliver res... Read more...
ELISA PROCESSING SYSTEM
The EUROLabWorkstation ELISA provides fully automated processing of EUROIMMUN ELISA tests at a capacity of up to 15 p... Read more...
CLINICAL CHEMISTRY REAGENTS
The Glenbio range of multipurpose clinical chemistry reagents provides customers with the choice of high quality, cos... Read more...
REAL-TIME PCR
The QuantGene 9600 real-time PCR features thermoelectric refrigeration technology, with a brand-new light source and ... Read more...
EBOLA TEST
The Ebola eZYSCREEN® is a rapid test for detection of Ebola virus (ZAIRE strain), allowing diagnosis of the disease w... Read more...
